Six from MIT awarded 2023 Paul and Daisy Soros Fellowships for New Americans
Fellowship funds graduate studies for outstanding immigrants and children of immigrants.
Fellowship funds graduate studies for outstanding immigrants and children of immigrants.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
When she’s not analyzing data about her favorite biomolecule, senior Sherry Nyeo focuses on improving the undergraduate experience at MIT.
Graduate students Alejandro Aguilera Castrejón and Melanie de Almeida honored for their passion for fundamental biology and discovery science.
Those selected for these positions receive additional support to pursue their research and develop their careers.
Researchers harness new pooled, image-based screening method to probe the functions of over 5,000 essential genes in human cells.
New prize program recognizes MIT researchers who make data openly accessible and reusable.
A new technique for studying liver cells within an organism could shed light on the genes required for regeneration.
Study finds the protein MTCH2 is responsible for shuttling various other proteins into the membrane of mitochondria. The finding could have implications for cancer treatments and MTCH2-linked conditions.
Awards support high-risk, high-impact research from early-career investigators.
Jonathan Weissman and collaborators used their single-cell sequencing tool Perturb-seq on every expressed gene in the human genome, linking each to its job in the cell.
Twenty winning projects will link industry member priorities with research groups across campus to develop scalable climate solutions.
Family trees of lung cancer cells reveal how cancer evolves from its earliest stages to an aggressive form capable of spreading throughout the body.
A Climate Grand Challenges flagship project aims to reduce agriculture-driven emissions while making food crop plants heartier and more nutritious.
Mary Gehring is using her background in plant epigenetics to grow climate-resilient crops.